Podcasts about rimidi

In this episode, we revisit our interview with Lucienne (Lucie) Ide, M.D., Ph.D., a healthcare innovator, the Founder and Chairman of Rimidi. Her diverse experiences in medicine, science, venture capital, and technology to transform the delivery of chronic care management.   Before starting Rimidi in 2012, Dr. Ide was a physicist at the National Security Agency, Raytheon Systems Corporation, and Monarch Capital Partners, a venture capital firm. She holds a joint M.D./Ph.D. degree from Emory University.

Brand de-positioning is a subtle and powerful way to stand apart in a crowded market. It focuses on what your organization can do for customers that competitors cannot. See how Rimidi successfully adopted this strategy and is seeing significant lead generation growth. To find out more about this approach, Swaay.Health sat down with Cortney Williams, Group Director, Health IT at Alloy and Emily Keough, Director of Marketing & Channel Partnerships at Rimidi (a client of Alloy). We asked them to explain de-positioning and how to get started with it. Learn more about Rimidi at https://rimidi.com/ Learn more about Alloy at https://alloycrew.com/

About Manny Montalvo:Manny Montalvo is SVP, Head of Digital Health & Innovation at Teva Pharmaceuticals since September 2021. Manny is responsible for overseeing the US Respiratory business, the US commercial innovation work, and the US and GLOBAL DIGIHALER® franchise. Manny's digital health team at Teva is entirely homegrown and has pioneered a class of digital pharmaceutical devices - a rarity in the pharmaceutical industry. Manny's charge at Teva is to encourage the use of digital therapeutics as part of the healthcare experience, making it seamless for both the healthcare providers and the patients they serve. With over 20 years of life-science experience, Manny Montalvo has held leadership roles in both Sales and Marketing, working in numerous therapeutic areas in the US and global markets, as well as in R&D and Commercial Operations. Prior to assuming his current role, Manny Montalvo served as the Vice President of Global Digital Health Marketing & Commercial Analytics at Teva Pharmaceuticals where he set the strategic direction for Teva's biologic program and Digital Health Marketing and transformation of Teva's Global Commercial Analytics. Manny joined Teva in 2013 to lead its R&D Innovation program as Vice President of Global New Therapeutic Entities (NTE) Innovation where he focused on the evaluation of the latest drug delivery technologies and drug development, adding more than 15 new products to Teva's specialty portfolio. Before joining Teva, Manny held leadership positions with P&L responsibilities at Sanofi and Johnson & Johnson. During his tenure at Sanofi and J&J, Manny worked in a variety of commercial roles including consumer marketing, driving growth for a range of portfolios including diabetes, dermatology, cardiovascular and primary care.  Things You'll Learn:Two out of five medicines in your cabinet are likely from Teva.A platform business has a feedback loop with customers.To innovate, one has to have a collaborative space supported by management.Teva Pharmaceuticals is partnering with Rimidi and HealthSnap, integrating their data as a step closer to fulfilling their mission. The more patients on Teva's platform, the better the technology gets.About 40% of Teva's digital space workers did not come from the traditional pharma industry. Resources:Connect with and follow Manny Montalvo on LinkedIn.Follow Teva Pharmaceuticals on LinkedIn.Visit the Teva Pharmaceuticals Website!Discover DIGIHALER here!

The constant need to re-share your health history with each new healthcare provider you encounter is frustrating and, unfortunately, all too common. It leads to wasted time, inaccuracies, and lost opportunities. Finding a way to improve archaic hospital and physician healthcare record systems takes someone who's been on the other side — in the physician's shoes. Rimidi, a clinical management platform software company, offers a solution that brings physicians' perspectives to bear. Tune in to hear Lucienne Ide, the Founder and CEO of Rimidi, as she shares her indirect route to entrepreneurship and the wealth of unique perspectives and experiences she's gained along the way. Tune in to learn:About Lucienne's winding career: From the NSA to investing, academia, healthcare, and finally entrepreneurship (03:47)About the great potential for improvement in diabetes care (12:29)A use case for how Rimidi is bringing change (18:28)About weighing social determinants and other healthcare factors (26:14)Our Automation Series is brought to you by Salesforce Platform and Dreamforce 2022! We don't want you to miss out on the world's largest software conference (with a healthy dose of magic), so log in to salesforce.com/plus for more automation-focused sessions.Mission.org is a media studio producing content for world-class clients. Learn more at mission.org.

On this podcast, Dr. Lucienne Ide, Founder and CEO of Rimidi, acknowledges the rapidly evolving healthcare market and discusses her passion for making healthcare scalable and better for all stakeholders by leveraging the right tools, insights, and analytics needed at the points of care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this podcast, Dr. Lucienne Ide, Founder and CEO of Rimidi, acknowledges the rapidly evolving healthcare market and discusses her passion for making healthcare scalable and better for all stakeholders by leveraging the right tools, insights, and analytics needed at the points of care. Rimidi is a clinical management platform designed to optimize clinical workflows. […]

In this podcast, Dr. Lucienne Ide, Founder and CEO of Rimidi, acknowledges the rapidly evolving healthcare market and discusses her passion for making healthcare scalable and better for all stakeholders by leveraging the right tools, insights, and analytics needed at the points of care. Rimidi is a clinical management platform designed to optimize clinical workflows. […]

“A lot has happened in healthcare in the past two years,” Lucienne Ide, Founder and CEO of Rimidi, says. “We went from a miniscule adoption of telemedicine—much less remote monitoring—to now everybody's looking at the future and saying, ‘This is here to stay. How are we going to do it in a scalable and sustainable way?'” Rimidi has the plan. Ide's focus is patients with chronic diseases. Episodic care is not working for them, she says, and a once-a-year or once-a-quarter trip to the doctor feels more like being called to the principal's office than a health-focused partnership. At Rimidi, Ide and her team are building sustainable progress by pushing healthcare past just digitizing data into true decision support for both patients and providers, innovating in care delivery and doing the “dirty work” of truly setting patients up for success. Ide and host, Steve Krupa, talk about the pain points in shifting to a value-based models; how EHRs, patients, and providers are responding to Rimidi's decision-support tools; and her best advice for healthcare entrepreneurs.Lucienne Marie Ide, MD, PhD, is the Founder and Chief Executive Officer of Rimidi, a cloud- based software platform that enables personalized management of health conditions across populations. She brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi's strategy and vision. Motivated by the belief that we can do so much better as individuals, in industry and society, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.

Rimidi is a cloud-based software platform that integrates with current clinical workflows to ensure smooth working of health systems and virtualize physician practices. Josh Claman, the CEO of Rimidi shares how COVID-19 has impacted the general healthcare system and what opportunities does Atlanta of 2021 provides to companies and new innovators.

In episode twenty-seven we speak with Lucie Ide the CEO at Rimidi about their clinical management platform, combining patient-generated health data with clinical data to improve outcomes, and her favorite places to travel!

Returning guest, Dr. Lucie Ide, MD, PhD, founder and CEO of Rimidi discusses why multiple point solutions in healthIT are only a temporary fix, how providers can integrate such solutions to achieve better health outcomes across their entire population of patients, and how combining remote patient monitoring (RPM), chronic care management (CCM), telehealth and patient reported outcomes (PROs) with clinical decision support solutions will further enable holistic care, and drive greater efficiency for staff. #Rimidi #ValueBasedCare Lucienne Marie Ide, M.D., PH.D., is the founder and CEO of Rimidi, a cloud- based software platform that enables personalized management of health conditions across populations. She brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi's strategy and vision. Motivated by the belief that we can do so much better as individuals, in industry and society, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.

Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) was growing before COVID and it's gaining even more traction since. However, many people underestimate what it takes to really do RPM and CCM well. To learn more about what it takes to do these well, we sat down with Josh Claman, CEO of Rimidi. We discuss how he sees the RPM market going (disease specific RPM or all in one RPM). We also discuss who should be managing the process and what reimbursement is still needed to make RPM better. Plus, we talk about their work with SMART on FHIR and the challenge of healthcare interoperability. Learn more about Rimidi: https://rimidi.com/ Find more great health IT content: https://www.healthcareittoday.com/

Host David Harlow talks to Josh Claman, CEO of Rimidi, who is on a mission to blur the lines between in-person episodic care and virtual continuous care, through EHR integration and human touch. David speaks with Josh about how this platform and this sector of remote patient monitoring has matured more quickly during the COVID era, and as we peer into the future of technology, health care and reimbursement. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, we are privileged to host Dr. Lucie Ide, Founder and Chief Health Innovator of Rimidi. Dr. Ide discusses how her company leverages technology and synthesized data to drive insights leading to workflow efficiency and improved outcomes. She explains the importance of data insights in providing effective remote monitoring and continuity of care for chronically ill patients especially those with diabetes. She shares her insights on provider-payer alignment, the slow adoption of technology in clinical practice, embracing new ideas, taking the first step in your idea, and more! This is a fascinating discussion, so please tune in! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Briana Contreras of MHE spoke with Josh Claman, CEO of Rimidi about the strong need for a permanent remote patient monitoring, or RPM, reimbursement reform, and how our health industry can come together to influence this change. The two also discussed the benefits of RPM technology for underserved, uninsured or Medicaid populations, and the benefits of RPM during and beyond the COVID-19 pandemic. 

Josh Claman, the CEO of Rimidi, discusses how remote monitoring devices can provide doctors with important patient health data while also creating a new revenue stream for practices.

Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need as a result of being disproportionately affected by COVID-19. Tara emphasizes the essential role technology must play in enabling data-driven healthcare and how the expanding use of mobile devices is leading to more opportunities to help vulnerable populations who need care. #COVID19 #digitalhealth #telehealth Rimidi.com Download the transcript here

Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need as a result of being disproportionately affected by COVID-19. Tara emphasizes the essential role technology must play in enabling data-driven healthcare and how the expanding use of mobile devices is leading to more opportunities to help vulnerable populations who need care. #COVID19 #digitalhealth #telehealth Rimidi.com Listen to the podcast here

Host Dr. Nick van Terheyden aka Dr. Nick's guest is the Founder & Chief Health Innovator of Rimidi, Lucienne Ide, MD, PhD discussing integrating patient data. How cloud based patient generated data is integrated into the broader health system. Interoperability and capitalizing on FHIR. And the HEAL initiative launched with CTA and Connected Health. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Josh Claman, MBA, CEO of Rimidi, a healthcare technology company, discusses how and why technology such as remote patient monitoring and telehealth should be used to predict future outbreaks and serve as early warning systems for detecting viruses in individuals. He also talks about how to address minority health inequities exposed during COVID-19.

Today's episode of Redefining Medicine features Lucienne M. Ide. Dr. Ide is a physician, scientist, and entrepreneur who is CEO of Rimidi, an IT company she founded in 2012 to address the challenging health and cost implications of common chronic diseases like diabetes. After earning a BA in physics from Middlebury College, Ide worked for the National Security Agency, Raytheon Systems, and Monarch Capital Partners. With a desire to shift her focus to health, Ide enrolled in the joint MD/PhD Medical Scientist Training Program at Emory University, which she completed in 2009. Dr. Ide, who lives in Atlanta, cofounded the Diabetes Prevention and Design Team, which is dedicated to reducing the prevalence of diabetes in the greater Atlanta community. Lucie brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi’s strategy and vision. Motivated by the belief that we can do so much better as individuals, an industry and society, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.

September 4, 2020: Meet health tech entrepreneur Lucie Ide, MD, PhD and Founder & Chief Health Innovator of Rimidi. A health tech company focused on bringing personalized management to chronic health conditions. Software for clinicians, by clinicians. She shares her sustainable business model. How do you get your best ideas? What is the market demand that you’re meeting? What's the revenue model for your product? How can you understand the pain points? From employee issues to founder issues to investor issues. And how do you handle tech debt as you mature as an organization? Step into the exciting mind of a scientist, clinician, academic and entrepreneur.Key Points:With the enormous amount of data being thrown at clinicians, how do they make sense of it in order to achieve evidence-based data driven decisions about patient care? [00:02:05]Scientific training as preparation for entrepreneurship [00:10:15] How do you make your product accessible and available? [00:14:20] What mistakes do people make when they pitch to venture capital firms? [00:20:35]The importance of networking and mentorship [00:24:35]rimidi.com Rimidi TwitterRimidi LinkedIn

In this episode, we interview Lucienne (Lucie) Ide, M.D., Ph.D., a healthcare innovator, the Founder and Chairman of Rimidi. Her diverse experiences in medicine, science, venture capital, and technology to transforming the delivery of chronic care management. Before starting Rimidi in 2012, Dr. Ide worked as a physicist at the National Security Agency, Raytheon Systems Corporation, and Monarch Capital Partners, a venture capital firm. She holds a joint M.D./Ph.D. degree from Emory University.

Hear how Rimidi is bringing visibility and management of chronic disease to clinical settings online.

Learn more about Rimidi by visiting https://rimidi.com/ and https://healthcare.rimidi.com/covid19

This Monday we take a look back at the biggest copyright cases of the year. Fourth Estate vs Wall-Street.com My favorite, the Fourth Estate versus Wall-Street, finally ended a split in the circuits. It used to be that the case really depended on where your copyright case was happening as to whether or not you could bring it before you got a copyright registration. That Supreme court ruling in Fourth Estate versus Wall-Street finally ended that circuit split. The U S Supreme court said in March that copyright owners must wait for the copyright office to give them the green light to sue. That means your copyright now must be registered. So copyright registration, more important than ever, before you can file suit. Do it early, do it often. Good rule for copyright registration. Rimini Street vs Oracle Another big decision was Rimini Street versus Oracle. That case said that costs, and again, this was a Supreme court case, unanimous decision written by Justice Kavanaugh, followed by the entire Supreme court, said that costs in a copyright case include attorney's fees but don't include these massive expanded costs that happened in the Rimidi case. $12 million, which included things like E-discovery and expert witness costs. Marcus Gray vs Katy Perry Another big decision I thought was kind of fun was the Marcus Gray versus Katy Perry - Joyful Noise case, which is on appeal. A jury verdict found that Katy Perry had infringed Joyful Noise.  Dr. Seuss Enterprises vs ComicMix Dr Seuss enterprises versus ComicMix addressed mashups and mashups is something that's I think we're going to see more of soon because in this decision, they said it was fair use. In other words, it was allowed for the company ComicMix to create a version of a Dr Seuss book because they had transformed the comic book efficiently.  Silver Top Associates vs Kangaroo Manufacturing In August, the third circuit cited the Star Athletica case, a Supreme court 2017 ruling when it said that this company Rasta Imposta, which had a copyright on its banana costume, could block a rival company called Kangaroo Manufacturing from selling a look alike costume. The court said, Rasta Imposta established a reasonable likelihood that it could prove entitlement to protection for the veritable fruits of its intellectual labor. 

Learn more about Rimidi by visiting https://rimidi.com/

Lucienne Ide started her career as a physicist working for a mobile company and then for a venture capital firm. When Lucienne kept receiving requests to help large corporations manage the cost of diabetes, she came up with the idea for Rimidi, a digital health start up focused on diabetes management. We discuss the alarming diabetes epidemic in America (research indicates half of Americans have diabetes or prediabetes!) We talk about the the need for more women to pursue career paths in digital health: although 80% of healthcare dollars are controlled by women, women are not represented in health IT as much as other healthcare fields within nursing and medicine. There is a tremendous opportunity to be a part of the growth in the digital health field in areas such as design, user experience, marketing, research, technology and more.

Rimidi This week we hosted the President and CEO of Rimidi, Dr. Luci Ide. Rimidi is a healthcare technology company that is working to help patients and health providers better manage diabetes. It’s an important endeavor—roughly 24 million Americans are diabetic and as many as 86 million more are pre-diabetic (slightly elevated fasting glucose levels). […] The post Rimidi appeared first on Business RadioX ®.

RIMIDI has spent the last few months putting the finishing touches on “Stone Cold” along with award winning and platinum selling producer, The Fabulous Moonshyne Brown. Together they have crafted a beautiful collection of songs that are sure to make an impact on fans who've been enjoying RIMIDI's style of Alternative-Psychedelic-Soul. RIMIDI has been entertaining enthusiastic music fans in Florida for several years is highly regarded as one of Miami's best live musical vocalists. The 1st single, "Grudges", can currently be downloaded FREE for a limited time at: http://rimidimusic.bandcamp.comRIMIDI is available for concert, club and festival appearances and performance dates, songwriting and print ads.  For Management, Licensing & Booking: rimidi@powerblastworldwide.net  Connect with Rimidi online: Reverbnation.com/Rimidi Twitter.com/RIMIDI Facebook.com/iLoveRIMIDImusic Youtube.com/RimidiMusic FindYourRimidi.tumblr.com

Special Guest: Actress, TV Personality,  "Enya Flack", Singer/Songwriter "Rimidi" and Filmmaker "Darren Saunders" Sponsored by: Positive Teen Magazine, It's a Glam Thing, Classic Cuts Barber Shop, NLPGimages.com, JazziDesigns Photograph, Kreative Kreations Accessories, & Kaizen Beauty Academy.   Hosted by: Sasha Marina   Produced by: Debye Johnson-Audain